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The proinflammatory cytokine tumor necro-
sis factor (TNF) a signals both cell survival
and death. The biological outcome of TNFa
treatment is determined by the balance be-
tweenNF-kBandJunkinase (JNK)signaling;
NF-kB promotes survival, whereas JNK
enhances cell death. Critically, identity of
a JNK substrate that promotes TNFa-
induced apoptosis has been outstanding.
Here we show that TNFa-mediated JNK ac-
tivation accelerates turnover of the NF-kB-
induced antiapoptotic protein c-FLIP, an in-
hibitor of caspase-8. This is not due to direct
c-FLIP phosphorylation but depends on
JNK-mediated phosphorylation and activa-
tionof theE3ubiquitin ligase Itch,whichspe-
cifically ubiquitinates c-FLIP and induces its
proteasomal degradation. JNK1 or Itch defi-
ciency or treatment with a JNK inhibitor ren-
ders mice resistant in three distinct models
of TNFa-inducedacute liver failure, andcells
from these mice do not display inducible
c-FLIPL ubiquitination and degradation.
Thus, JNK antagonizes NF-kB during TNFa
signaling by promoting the proteasomal
elimination of c-FLIPL.
INTRODUCTION
Tumor necrosis factor (TNF) a is a prototypical, proinflamma-
tory cytokine that can signal, through its type 1 receptor
(TNFR1), either cell survival, cell proliferation and activation,or cell death (Wajant et al., 2003). Binding of TNFa to
TNFR1 results in sequential formation of two signaling com-
plexes (Micheau and Tschopp, 2003; Muppidi et al., 2004).
The rapidly forming complex I is assembled on the receptor’s
cytoplasmic tail and consists of the adaptor TRADD, the pro-
tein kinase RIP1, and the signal transducer TRAF2. This
complex signals inflammation and cell survival through IkB
kinase (IKK) dependent activation of transcription factor
NF-kB (Liu et al., 1996). Subsequently, complex I dissociates
from the receptor, and TRADD together with RIP1 associate
with the adaptor protein FADD and pro-caspase-8 (also
called FLICE) to form complex II. In cells that lack substantial
NF-kB activity, formation of complex II results in caspase-8
activation and apoptotic cell death (Muppidi et al., 2004).
However, if NF-kB has been activated during complex I for-
mation, it prevents caspase8 activation by complex II
through induction of cellular FLICE-inhibitory protein
(c-FLIP, also called CASH, Casper, CLARP, FLAME, I-FLICE,
MRIT, or Usurpin), an adaptor protein with a pseudo-
caspase domain, which specifically inhibits caspase-8
(Thome and Tschopp, 2001). Thus, NF-kB may negatively
regulate TNFa-induced apoptosis through regulation of
c-FLIP levels, and its activation serves as a checkpoint that
determines whether complex II will signal cell death or not
(Muppidi et al., 2004). NF-kB was also suggested to inhibit
TNFa-induced cell death through additional mediators
(Wang et al., 1998). Nonetheless, the c-FLIP-dependent
mechanism has received physiological support through
analysis of Flip/ fibroblasts which undergo TNFainduced
apoptosis even without inhibition of NF-kB-dependent gene
expression (Yeh et al., 2000).
Multiple c-Flip mRNA splice isoforms give rise to either
a long FLIP (cFLIPL) polypeptide of 55 kDa, a short FLIP
polypeptide (cFLIPS) of 26 kDa (Irmler et al., 1997a;
Krueger et al., 2001a), or a third 23 kDa recently identified
form, called FLIPR (Golks et al., 2005). Due to its structural
similarity to caspase-8 and caspase-10, c-FLIPL undergoes
caspasemediated cleavage to generate a 43 kDa isoform
that still contains death effector domains (DED) and the
pseudo-caspase motif and can therefore remain bound toCell 124, 601–613, February 10, 2006 ª2006 Elsevier Inc. 601
FADD and inhibit complete caspase-8 processing and acti-
vation (Krueger et al., 2001b).
In addition to NF-kB, another important regulator of TNFa
signaling is Jun kinase (JNK), a member of the MAP kinase
(MAPK) subfamily (Varfolomeev and Ashkenazi, 2004). It is
well established that the balance between NF-kB and JNK
activities determines the outcome of TNFa signaling, such
that NF-kB promotes cell survival, whereas prolonged JNK
activation enhances TNFa-induced death (De Smaele
et al., 2001; Karin and Lin, 2002; Papa et al., 2004; Tang
et al., 2001). We have shown that NF-kB controls the dura-
tion of JNK activation through induction of genes encoding
antioxidant proteins, such as superoxide dismutase (SOD)
2, that prevent oxidation and subsequent inhibition of
MAPK phosphatases (MKPs) by reactive oxygen species
(ROS) (Kamata et al., 2005). The molecular mechanism
through which prolonged JNK activation promotes TNFa-
induced death, however, remained elusive. It was recently
proposed that JNK activation somehow promotes process-
ing of the BH3-domain protein Bid to proapoptotic cleavage
products, such as tBid (Luo et al., 1998) and jBid (Deng et al.,
2003), that allow TNFa-induced apoptosis to proceed.
Nonetheless, a JNK-dependent phosphorylation event that
controls Bid processing or the activity of any defined compo-
nent of the TNFR1-activated death or survival machinery has
not been identified.
We now show that JNK activity controls TNFa-induced
death through the proteasomal processing of c-FLIPL, the
very molecule that inhibits the apoptotic activity of complex
II and whose expression is NF-kB dependent (Micheau
and Tschopp, 2003). Instead of direct c-FLIPL phosphoryla-
tion, JNK promotes accelerated decay of c-FLIPL through
activation of the ubiquitin ligase Itch, the first member of
the HECT family of E3 ligases whose catalytic activity was
shown to be phosphorylation (JNK1) dependent (Gao
et al., 2004). Importantly, JNK1- and Itch-deficient mice,
as well as mice given a specific JNK inhibitor, are resistant
to three different models of fulminant hepatitis, a pathological
response that depends on TNFR1 activation (Maeda et al.,
2003). These mice fail to ubiquitinate and degrade c-FLIPL
in response to hepatitis-inducing challenges, and their hepa-
tocytes do not undergo apoptosis when challenged with
TNFa and a transcriptional inhibitor.
RESULTS
JNK1 Is Specifically Required for TNFR1-Induced
Apoptosis but Cannot Induce Apoptosis on Its Own
The midgestational lethality due to massive liver apoptosis of
NF-kB-deficient mice, which is common to mice lacking
RelA, IKKb, or IKKg, is completely suppressed by removal
of either TNFa or TNFR1 (reviewed by Karin and Lin,
2002). To investigate the role of JNK1 in TNFR1 death signal-
ing in mice lacking IKKb, we crossed Ikkb+/ and Jnk1+/
heterozygote mice to generate Ikkb//Jnk1/ double mu-
tants. In these and subsequent experiments, we chose to
use JNK1-deficient mice and cells because it has been
noticed that JNK1 rather than JNK2 is required for TNFa-602 Cell 124, 601–613, February 10, 2006 ª2006 Elsevier Inc.induced apoptosis (Liu et al., 2004; L.C., unpublished
data). The absence of JNK1 delayed the lethality caused
by removal of IKKb by 4 days (Figure 1A). Histological anal-
ysis of livers from E14.5 fetuses revealed extensive hepato-
cyte apoptosis in Ikkb/ fetuses, which was absent in
Ikkb//Jnk1/double mutants (Figure 1B). These results
underscore the physiological importance of the previously
described crosstalk between IKKb-NF-kB and JNK1. Ac-
cordingly, primary hepatocytes from Jnk1/ mice were re-
sistant to apoptosis induced by incubation with TNFa plus
cycloheximide (to inhibit expression of survival genes) and
failed to cleave caspase-8 and -9 (Figure 1C). These cells
also exhibited reduced levels of caspase-3 cleavage and
cytochrome c release in comparison to similarly treated
wild-type (wt) cells.
Despite the clear evidence, here and elsewhere (De
Smaele et al., 2001; Kamata et al., 2005; Tang et al.,
2001), that prolonged JNK activation is important for
TNFa-induced death of NF-kB-deficient cells, it has been
questioned whether prolonged JNK activation alone is suffi-
cient to induce apoptosis in the absence of TNFR1 activation
(Liu et al., 1996; Tang et al., 2001; Varfolomeev and Ashke-
nazi, 2004). This is an important issue, as its resolution
should indicate whether JNK regulates a specific compo-
nent of the TNFR1 death signaling pathway or a more gen-
eral and downstream aspect of the apoptotic machinery.
To answer this question, we transfected Ikkb/ fibroblasts,
which undergo cell death upon incubation with TNFa alone,
with a JNK1 expression vector alone or together with a dom-
inant-negative MKP-7 mutant, MKP-7DC(C244S), that al-
lows prolonged JNK activation in response to cell stimulation
due to inhibition of endogenous MKPs (Kamata et al., 2005).
As expected, prolonged JNK activation was observed in
cells expressing MKP-7DC(C244S) that were stimulated
with IL-1, but despite that and the absence of IKKb, these
cells did not die (Figure 1D). As before, substantial cell death
was seen in TNFa-stimulated Ikkb/ fibroblasts, and it was
not further enhanced by expression of the mutant MKP.
These results indicate that prolonged JNK1 activation alone
is not sufficient for activation of the apoptotic machinery even
in IKKb- (and NF-kB-) deficient cells. These findings there-
fore suggest that JNK1 targets a specific component of
TNFR1 signaling to allow TNFa-induced apoptosis and
does not act on a downstream target that is common to sev-
eral distinct apoptosis signaling pathways.
JNK Controls c-FLIPL Stability
As mentioned above, TNFR1 death signaling depends on
the progression from complex I to complex II, and the ability
of caspase-8, a key component of complex II, to undergo
activation (Micheau and Tschopp, 2003). Activation of cas-
pase-8 ismodulated by the levels of c-FLIP, its specific inhib-
itor (Krammer, 2000). Importantly, transcription of the c-Flip
gene, which gives rise to c-FLIPL and c-FLIPS isoforms, is
controlled by NF-kB (Micheau et al., 2001), and Flip/ fibro-
blasts undergo apoptosis when incubated with TNFa alone
(Yeh et al., 2000). To examine the effect of JNK1 on various
components of the TNFR1 signaling machinery, including
Figure 1. Prolonged JNK1 Activation Is Required for TNFa-Dependent Cell Death In Vivo but Does Not Kill Cells in the Absence of
TNFa
(A) wt, Ikkb/, Jnk1/, and Ikkb//Jnk1/mouse fetuses were isolated and examined at the indicated embryonic days (E). Ikkb/ fetuses are dead at
E14.5, whereas Ikkb//Jnk1/ fetuses survive until E17.5.
(B) Histological analysis of livers from wt, Ikkb/, Jnk1/, and Ikkb//Jnk1/ E14.5 fetuses. Tissue sections were analyzed by H&E and TUNEL staining
(original magnification 400).
(C) JNK1 is required for TNFa-induced hepatocyte apoptosis. Primary hepatocytes from wt and Jnk1/ E14.5 fetuses were treated with TNFa (10 ng/ml)
plus cycloheximide (CHX, 100 mg/ml) for the indicated times. Caspase cleavage and cytochrome c release were monitored by immunoblotting of postmi-
tochondrial supernatants with appropriate antibodies.
(D) Prolonged JNK activation without TNFa is not sufficient for killing of Ikkb/ fibroblasts. Upper panel: Viability of Ikkb/ fibroblasts after transfection with
HA-tagged JNK1 or GFP expression vectors with or without a catalytically inactive MKP-7 expression plasmid [MKP-7DC(C244S)] was assessed by propi-
dium iodide (PI) dye exclusion assay and flow cytometry (upper panel). The cells were incubated at time = 0 (36 hr after transfection) with TNFa or IL-1. Lower
panels: The kinetics of JNK activation were determined by the solid state kinase assay (KA) with GST-c-Jun (1–79) as a substrate.c-FLIP, in an in vivo setting, we injected mice with ConA,
a potent activator of T cells that triggers TNFR1-dependent
hepatocyte death, thereby causing fulminant and lethal hep-
atitis (Maeda et al., 2003). Immunoblot analysis revealed that
mouse liver contained mostly the c-FLIPL isoform, even prior
to ConA administration (Figure 2A). c-FLIPL, unlike c-FLIPS,
contains a pseudo-caspase domain and is therefore a spe-
cific caspase-8 inhibitor (Irmler et al., 1997b; Krueger et al.,
2001a, 2001b). ConA injection to wt mice caused degrada-
tion of c-FLIPL and appearance of an apoptotic DNA ladder(Figure 2A). ConA injection also caused cleavage of cas-
pases-8 and -3 and cytochrome c release (Kamata et al.,
2005). By contrast, very little c-FLIPL degradation or apopto-
sis were detected upon ConA injection to Jnk1/ mice
(Figure 2A). Such mice also showed little or no cleavage of
caspase-3 and cytochrome c release (Kamata et al., 2005).
For further biochemical analysis of c-FLIP turnover, we
switched to cultured hepatocytes. Again, treatment with
TNFa plus cycloheximide reduced the levels of c-FLIPL,
the predominant form of c-FLIP in wt hepatocytes, and thisCell 124, 601–613, February 10, 2006 ª2006 Elsevier Inc. 603
Figure 2. TNFa Induces JNK1-Dependent c-FLIP Degradation
(A) Livers were isolated at the indicated times after ConA injection (25 mg/kg) from wt and Jnk1/mice, lysed, gel separated, and immunoblotted with an
anti-c-FLIP antibody. The same membrane was reprobed with anti-actin antibodies to monitor loading. Relative c-FLIP amounts (RA) determined by phos-
phoimaging are presented underneath the upper panels. Liver genomic DNA was isolated before and 8 hr after ConA injection and analyzed by agarose gel
electrophoresis for a nucleosomal ladder indicative of apoptosis (lower panel).
(B) JNK1 is required for c-FLIP degradation. Upper panels: Primary wt and Jnk1/ hepatocytes were treated with TNFa (10 ng/ml) and CHX (100 mg/ml) and
analyzed at the indicated times (hr) by immunoblotting for levels of c-FLIP, RIP1, and Bid. Actin was used as a loading control. Lower panels: Primary
Jnk1/ hepatocytes were transduced with lentiviruses expressing GFP or HA-tagged JNK1. c-FLIP and JNK1 levels were examined by immunoblotting.
(C) Total RNA isolated at the indicated times (hr) from primary wt and Jnk1/ hepatocytes after stimulation by TNFa (10 ng/ml) was subjected to Q-PCR
analysis to determine mean relative mRNA levels of c-FLIP, cIAP1, cIAP2, and A20. The data shown are the means ± SD (n = 3).
(D) wt and Jnk1/ mice were injected with ConA (25 mg/kg) and at the indicated times their livers were isolated and homogenized. Upper panels: Liver
lysates were immunoprecipitated with anti-FADD antibodies and analyzed by immunoblotting with antibodies against c-FLIP, caspase-8, and FADD. Lower
panels: Total JNK activity in liver lysates was determined by the solid state kinase assay.was followed by cleavage of Bid and appearance of tBid
(Figure 2B, upper panels). By contrast, the same treatment
of Jnk1/ hepatocytes did not decrease c-FLIPL expression
and caused very little Bid cleavage. The TNFa-induced
decrease in c-FLIPL was indeed JNK1 dependent because604 Cell 124, 601–613, February 10, 2006 ª2006 Elsevier Inc.infection of Jnk1/ hepatocytes with a JNK1-expressing
lentivirus, but not a GFP lentivirus, restored TNFa-induced
c-FLIP degradation (Figure 2B, bottom panels). Real-time
quantitative PCR (Q-PCR) analysis revealed normal induc-
tion of c-Flip mRNA in Jnk1/ hepatocytes and livers after
Figure 3. Proteasome Activity Is Required for TNFa-Induced c-FLIP Degradation and Cell Death
(A) Primary wt hepatocytes were incubated with or without the proteasome inhibitor MG-132 30 min prior to addition of TNFa (10 ng/ml) and CHX
(100 mg/ml). At the indicated times (hr), cell lysates were prepared and analyzed by immunoblotting with antibodies for c-FLIPL, IkBa, caspase-3, and actin.
(B) shows c-FLIP ubiquitination in livers of ConA-injected mice. wt and Jnk1/mice were given either vehicle (PBS) or 15.7 ng of a D-JNKi peptide in PBS
i.c.v. 30 min before injection of ConA (25mg/kg). Livers were isolated at the indicated times (hr), lysed, and immunoprecipitated with anti-c-FLIP antibodies,
gel separated, and immunoblotted with anti-ubiquitin antibodies.
(C) shows Kaplan-Meier survival plot for IkkbDhep mice given PBS or the proteasome inhibitor bortezomib (1 mg/kg) 1 day prior to injection of ConA
(25 mg/kg).
(D) Ikkb/ fibroblasts were infected with either GFP- or p43-c-FLIPL-expressing lentiviruses and incubated with TNFa (10 ng/ml). After 8 hr, the cells were
examined by either PI staining and fluorescent microscopy or bright-field (Br) microscopy.stimulation with either TNFa plus cycloheximide or ConA
(Figure 2C and data not shown). Thus, JNK1 is likely to con-
trol c-FLIPL abundance at a posttranscriptional level. Con-
sistent with the results of the RNA and immunoblot analyses,
very little c-FLIPL was associated with FADD in livers of wt
mice either before or after ConA injection, whereas the levels
of FADD-associated c-FLIPL were increased in livers of
Jnk1/ mice after ConA injection (Figure 2D). A reciprocal
relationship was found for caspase-8 association with
FADD: very little pro-caspase-8 was brought down by the
anti-FADD antibody in Jnk1/ livers, whereas pro-cas-
pase-8 was readily detected in FADD immunoprecipitates
from wt liver—especially after ConA administration.A major posttranscriptional mechanism that controls
protein levels in eukaryotic cells is ubiquitin-dependent
proteasomal turnover (Ciechanover and Schwartz, 2004).
To examine proteasome involvement in TNFa-induced
c-FLIP decay, we treated cultured hepatocytes with the
specific proteasome inhibitor MG132 (Rock et al., 1994).
Pretreatment with MG132 completely prevented TNFa-
induced c-FLIPL degradation in wt hepatocytes (Fig-
ure 3A). MG132 pretreatment also inhibited TNFa-induced
IkBa degradation (seen at the 1 hr time point) and prevented
caspase-3 cleavage. These results suggest that TNFa
induces JNK1-dependent proteasomal degradation of
c-FLIP.Cell 124, 601–613, February 10, 2006 ª2006 Elsevier Inc. 605
Proteasomal degradation depends on protein polyubiqui-
tination (Ciechanover and Schwartz, 2004). Indeed, in wt
miceConAadministration resulted in appearanceofpolyubiq-
uitinated forms of c-FLIPL as early as 30 min postinjection
(Figure 3B). Much less ConA-induced c-FLIPL ubiquitination
was seen in ConA-injected Jnk1/ mice or wt mice pre-
treated with a specific JNK-inhibitory peptide, D-JNKi (Bor-
sello et al., 2003). This peptide also conferred resistance to
ConA-induced fulminant hepatitis (Figure S1). Protection
against ConA-induced fulminant hepatitis and death was
also seen in IkkbDhep mice injected with another specific pro-
teasome inhibitor—bortezomib (Valcade, formerly PS-341)
(Adams, 2004) (Figure 3C). Thus, despite the ability of pro-
teasome inhibitors to inhibit NF-kB activation, when added
prior to TNFa or ConA, they can prevent TNFa-induced cell
death in hepatocytes or liver of animals that are compro-
mised in NF-kB activation. This protective effect is most likely
due to stabilization of c-FLIPL (Figure 3A) because infection
of Ikkb/ cells with a lentivirus encoding the p43 form of
c-FLIPL, but not with a GFP lentivirus, prevented TNFa-
induced apoptosis (Figure 3D).
Itch Activity Is Required for TNFa-Induced
c-FLIPL Degradation
The results shown above indicate that TNFa induces c-FLIPL
degradation in a JNK-dependentmanner by inducing its poly-
ubiquitination. As phosphorylation can tag specific proteins
for polyubiquitination and proteasomal degradation, e.g.,
the IkBs (Karin and Ben-Neriah, 2000), we investigated
whether JNK1 could directly phosphorylate c-FLIPL. The re-
sults of these experiments were negative, and examination
of the c-FLIPL sequence did not reveal obvious JNK docking
or phosphoacceptor sites (data not shown). Recently we
found that JNK1 can signal specific protein ubiquitination
and degradation via phosphorylation-dependent activation
of the ubiquitin ligase Itch (Gao et al., 2004). We therefore ex-
amined the susceptibility of fibroblasts from Itchy mutant
mice, which do not express Itch (Fang et al., 2002) to
TNFa-induced apoptosis. Strikingly, incubation of such cells
with TNFa plus cycloheximide resulted in very little apoptosis
within 8 hr, a time point at which many wt fibroblasts dis-
played an apoptotic phenotype (Figure 4A). Accordingly, in-
cubation of Itch/ fibroblasts with TNFa plus cycloheximide
resulted in very little and extensively delayed caspase-8
cleavage, delayed caspase-3 activation, and no c-FLIPL
degradation (Figure 4B). Similar results were obtained
when instead of cycloheximide the different fibroblast cul-
tures were transduced with an adenovirus encoding IkBa
superrepressor (IkBa-SR) to inhibit NF-kB. Whereas TNFa
treatment of wt cells transduced with this virus resulted in
apoptosis and c-FLIPL degradation, very little apoptosis or
c-FLIPL degradation were seen in Itch
/ or Jnk1/ fibro-
blasts (Figure 4C). Reconstitution of Itch/ fibroblasts with
a lentivirus encoding wt Itch restored TNFa-induced c-FLIPL
degradation and apoptosis, while very little apoptosis or
c-FLIPL degradation was seen in Itch
/ cells transduced
with a lentivirus encoding a mutant form of Itch, AA-Itch,606 Cell 124, 601–613, February 10, 2006 ª2006 Elsevier Inc.which is refractory to JNK1-induced phosphorylation
(Figure 4D; Figure S2).
In transient transfection experiments, we found that coex-
pression of Itch with c-FLIPL resulted in polyubiquitination of
the latter that was seen only in cells treated with the protea-
some inhibitor MG132 (Figure 4E). Itch-induced ubiquitina-
tion of c-FLIPL was augmented by coexpression of activated
JNK1, a JNK1-JNKK2 fusion protein (Zheng et al., 1999).
Coexpression of the antiapoptotic proteins cIAP1 or cIAP2,
which contain a RING-finger domain that possesses E3
ligase activity (Yang et al., 2000), instead of Itch did not stim-
ulate c-FLIPL ubiquitination (Figure 4E). Coexpression of
normal JNK1 had only a small stimulatory effect on basal
Itch-induced c-FLIPL ubiquitination, but the ubiquitination
response seen in the presence of JNK1 was strongly stimu-
lated by incubating the transfected cells with TNFa (Fig-
ure 4F). TNFa weakly enhanced Itch-induced c-FLIPL ubiq-
uitination in the absence of cotransfected JNK1.
Itch Selectively Interacts with c-FLIPL
To further characterize the functional interaction between
Itch and c-FLIP, we examined whether the two proteins di-
rectly interact. In addition to full-length c-FLIPL and c-FLIPS,
we also used two different subfragments of c-FLIPL corre-
sponding to its N-terminal DEDs and its C-terminal cas-
pase-8-like domain (CASP). In GST-pulldown experiments,
full-length c-FLIPL or its CASP domain, but neither c-FLIPS
nor theDEDportion, were found to bindGST-Itch (Figure 5A).
These interactions were of functional relevance because in
cotransfection experiments similar to those described in
Figure 4E, coexpression of Itch and activated JNK1 pro-
moted the ubiquitination and degradation of c-FLIPL but
not c-FLIPS (Figure 5B). Note that no TNFa-enhanced
c-FLIPL ubiquitination is seen in this experiment because
the JNK1 construct is a constitutively active JNKK2-JNK1
fusion protein. The time-dependent c-FLIPL degradation in
this figure is due to the inhibition of new protein synthesis
by cycloheximide. Even after TNFa plus cycloheximide treat-
ment, c-FLIPS, unlike c-FLIPL, remained stable. Similar
results were obtained in pulse-chase experiments (Fig-
ure 5C). Whereas Itch together with activated JNK1 induced
rapid decay of both full-length (p55) and p43 c-FLIPL, it failed
to alter the amount of radiolabeled c-FLIPS. Thus, Itch selec-
tively interacts with the CASP domain that is present in
c-FLIPL and this interaction is of functional relevance.
ItchyMutant Mice Are Resistant to TNFa-Dependent
Fulminant Hepatitis
If Itch is required for TNFa-induced c-FLIPL degradation
in vivo and this is required for TNFa-induced PCD, the
absence of Itch activity should protect mice from TNFa-
induced lethality. To examine this prediction, we injected
wt, Jnk1/, and Itchy mice (all in the C57BL6 background)
with ConA. Histological analysis revealed extensive liver
damage in wt mice within 8 hr of ConA administration, but
very little damage was observed and tissue integrity was re-
tained in Jnk1/ and Itchy mice (Figure 6A). Similar obser-
vations were made by measuring the circulating levels of
Figure 4. Itch Is Required for c-FLIP Degradation and TNFa-Induced Apoptosis
(A) wt and Itch/ fibroblasts were incubated with TNFa (10 ng/ml) and CHX (100 mg/ml). After 8 hr, apoptotic cells were visualized by PI staining.
(B) c-FLIP protein levels and caspase-8 and -3 cleavage were analyzed in wt and Itch/ fibroblasts after TNFa plus CHX treatment.
(C) wt, Itchy (Itch/), and Jnk1/ fibroblasts were transduced with an adenovirus encoding IkBa superrepressor (IkBaSR) to inhibit NF-kB. TNFa (10 ng/
ml) was added and at the indicated times cell lysates were prepared and c-FLIPL degradation was examined as above. The extent of apoptosis in parallel
treated cultures was examined by propidium iodide staining, and relative rates of apoptotic cell death are indicated below.
(D) Itchy fibroblasts were transduced with lentiviruses encoding GFP, wt Itch, or AA-Itch, a mutant in which the D domain required for JNK1 binding and Itch
phosphorylation was inactivated (Gao et al., 2004). After 24 hr, the cells were incubated with TNFa plus CHX and Itch expression and c-FLIP degradation
was assessed by immunoblotting. Note that the titre of the AA-Itch virus was somewhat higher than that of the wt-Itch virus, and the cells at the 0 time point
received more virus.
(E) Itch induces c-FLIPL ubiquitination. 293T cells were transfected with Myc-tagged-c-FLIPL, Xpress-tagged Itch, HA-ubiquitin with or without
JNKK2-JNK1 (JNK*) expression plasmids. cIAP1 and cIAP2 expression vectors were used as controls for the Itch expression vector. After 36 hr, cells
were incubated with TNFa plus CHX for 8 hr and c-FLIPL ubiquitination was examined by immunoprecipitation with anti-Myc antibodies and immunoblotting
with anti-HA antibodies. Expression of Itch (not shown) was detected with anti-Xpress antibodies.
(F) TNFa stimulates c-FLIPL ubiquitination. 293T cells were transiently transfected with plasmids encoding Myc-tagged c-FLIPL, ubiquitin, and Itch with
or without (Mock) a JNK1 vector. The cells were preincubated with MG-132 for 30 min and stimulated with TNFa for the indicated duration (min). After immu-
noprecipitation with anti-Myc, ubiquitination of c-FLIPL was examined by immunoblotting as described above. Itch levels were examined by immunoblotting.alanine aminotransferase (ALT), a liver enzyme whose pres-
ence in the circulation is an indicator of liver damage: circu-
lating ALT levels were strongly elevated in wt mice 8 hr after
ConA administration, while only a small increase in circulat-ing ALT was seen in similarly treated Itchy mice (Figure 6B).
Accordingly, ConA administration led to c-FLIPL degradation
in wt but not in Itchy mice (Figure 6C). ConA-induced hepa-
titis depends on production of several cytokines, includingCell 124, 601–613, February 10, 2006 ª2006 Elsevier Inc. 607
Figure 5. Itch Selectively Interacts with c-FLIPL and Induces Its Degradation but Does Not Affect c-FLIPS
(A) Reticulocyte lysates were programmed with His-tagged expression vectors for c-FLIPL, c-FLIPS, and the DED or CASP regions of c-FLIPL. A portion of
each lysate was saved, whereas the rest was subjected to pulldown with recombinant GST-Itch. The saved lysates and eluates from the GST-Itch beads
were analyzed by immunoblotting with anti-His antibodies. An anti-Itch antibody was used to examine the amount of GST-Itch in each precipitate. Shown
below is a schematic representation of the FLIP expression constructs.
(B) shows comparison of c-FLIPL and c-FLIPS ubiquitination. 293T cells were transfected with either Myc-tagged c-FLIPL or c-FLIPS vectors together with
Itch, ubiquitin, and JNKK2-JNK1 expression plasmids. After 36 hr, the cells were incubated with TNFa (10 ng/ml) and CHX (100 mg/ml) for the indicated
times. Ubiquitination of c-FLIP isoforms was assessed as described in Figure 4 after immunoprecipitation with anti-Myc antibody. The total levels of c-FLIP
isoforms were examined by immunoblotting.
(C) Itch induces selective degradation of c-FLIPL. 293T cells were transfected with Myc-tagged c-FLIPL or c-FLIPS expression vectors along with Itch, ubiq-
uitin, and JNKK2-JNK1 expression plasmids. After 24 hr, the cells were pulse labeledwith a [35S]trans-label for 1 hr and chasedwith nonradioactive cysteine
and methionine containing medium for the indicated times. Cell lysates were immunoprecipitated with anti-Myc antibodies, separated on 12% NuPAGE
gels, and fluorographed.TNFa, interferon (IFN) -g, IL-4, and Fas ligand (FasL), by NKT
cells (Tiegs et al., 1992). The Itchymutation increases the ex-
pression of Th2 cytokines, such as IL-4, while having no ef-
fect on Th1 cytokines, such as IFN-g (Fang et al., 2002).
As expected, we found no change in expression of TNFa,
IFN-g, and FasL mRNAs after ConA injection between wt
and Itchy mice, while the levels of IL-4 mRNA were elevated
in the mutant (Figure 6D). Thus the protection against ConA-
induced fulminant hepatitis in Itchymice is unlikely to be due
to defective cytokine gene expression.
We also examined JNK-dependent c-FLIPL degradation
in a different model of acute liver failure, this time induced
by coadministration of bacterial lipopolysaccharide (LPS)608 Cell 124, 601–613, February 10, 2006 ª2006 Elsevier Inc.and D-galactosamine (GalN). While LPS leads to rapid acti-
vation of macrophages that produce copious amounts of
TNFa, GalN is a specific inhibitor of gene transcription in
hepatocytes (Decker and Keppler, 1974), and it therefore
prevents the induction of antiapoptotic genes only in this
cell type. While administration of LPS + GalN to wt mice
resulted in massive liver damage and lethality, treatment of
these mice with the JNK inhibitor D-JNKi prevented hepato-
cyte apoptosis and no liver damage could be detected (Fig-
ure S3). Importantly, administration of the JNK inhibitor
inhibited the ubiquitination of c-FLIPL and prevented its deg-
radation (Figure 6E). The effect was not due to reduced TNFa
production (Figure S3). Nonetheless, to completely rule out
Figure 6. Itch Is Required for ConA-Induced Fulminant Hepatitis and c-FLIPL Degradation
(A) Histological analysis of livers fromwt, Jnk1/, and Itch/mice before and 8 hr after ConA (25mg/kg) challenge. Tissue sections were subjected to H&E
staining and examined by microscopy (original magnification 400). Similar results were obtained by analysis of three additional mutant mice on two sep-
arate occasions.
(B) wt and Itch/mice were injected with ConA, and serum samples were removed at 0 and 8 hr for measurement of ALT levels (units/ml). The results are
average values for two mice per genotype.
(C) Livers of wt and Itc / mice were isolated 0 and 8 hr after ConA injection, and c-FLIPL levels were determined by immunoblotting. Actin was used as
loading control.
(D) Livers from wt and Itch/mice were collected 0 and 8 hr after ConA injection and total RNA was isolated for Q-PCR analysis of the indicated cytokine
mRNAs. The data shown are the means ± SD (n = 3 or 4).
(E) wt mice were injected i.p. with LPS and Gal-N. Half of the treatment group was also injected with a JNK inhibitor (D-JNKi, 30 ng/mouse) or PBS. At the
indicated points, the mice were sacrificed and their livers removed for biochemical and histological analyses. c-FLIP ubiquitination was analyzed as de-
scribed above by immunoprecipitation with anti-FLIP antibody and immunoblotting with anti-ubiquitin antibody. c-FLIP amounts were determined by im-
munoblotting.a contribution of altered TNFa synthesis, we administered
TNFa +GalN to wt and Itch/mice. Whereas this treatment
led to severe liver damagewithin 7 hr in wtmice, Itch/mice
did not display any obvious histological liver damage and
were resistant to TNFa-induced morbidity (Figure S4). In ad-
dition, we reconstituted lethally irradiated wt mice with bone
marrow of either wt of Jnk1/ mice, whereas lethally irradi-
ated Jnk1/mice were reconstituted with wt bone marrow.
After 8–10 weeks, these mice were challenged with TNFa +
GalN. Whereas mice with wt stroma (i.e., the radiation-resis-
tant compartment) were highly sensitive to TNFa + GalN and
exhibited severe liver damage with characteristic necrotic
and hemorrhagic lesions, mice with a Jnk1/ stroma were
resistant to TNFa + GalN and their livers retained normalmorphology at 8 hr post-challenge (Figure S5). These results
confirm that the sensitivity to TNFa-induced death is deter-
mined by the genotype of the hepatocyte and not bone
marrow-derived cells and that the resistance displayed by
Itch- or JNK1-deficient mice is not due to reduced TNFa pro-
duction, processing, or secretion.
DISCUSSION
The ability of NF-kB to inhibit TNFa-induced cell death is well
established and was seen on many different occasions both
in vitro and in vivo (reviewed by Karin and Lin, 2002). Further-
more, rapid activation of IKK and NF-kB by TNFa explains, in
part, its poor ability to trigger cell death in comparison toCell 124, 601–613, February 10, 2006 ª2006 Elsevier Inc. 609
other family members that are weak NF-kB activators, such
as FasL (Micheau and Tschopp, 2003; Muppidi et al., 2004).
By contrast, the role of JNK in the control of TNFa-induced
cell death has been controversial, and its mechanism of ac-
tivation remained enigmatic. In recent years, it was shown,
initially in cultured cells (De Smaele et al., 2001; Tang
et al., 2001) and now in vivo (Figure 1) that one of the antiap-
optotic mechanisms through which NF-kB acts depends on
termination of JNK activation. This was shown to be due to
the ability of NF-kB to induce genes encoding antioxidants
(Pham et al., 2004), which prevent oxidative inhibition of
JNK phosphatases (Kamata et al., 2005). Yet, the exact
mechanism through which JNK activation promotes TNFa-
induced apoptosis remained unknown. Recently, it was sug-
gested that JNK is likely to act at a step upstream to cas-
pase-8 perhaps through generation of a novel Bid cleavage
product, jBid (Deng et al., 2003). But even that work failed
to identify a JNK-dependent phosphorylation event or a
JNK substrate that promotes TNFa-induced apoptosis.
The experiments described above address this deficiency
in our understanding of TNFa signaling by identifying a novel
regulatory step and a direct JNK substrate needed for pro-
gression from TNFR1-assembled signaling complexes to
caspase-8 activation. Our results demonstrate, both in vitro
and in vivo, that TNFa-induced apoptosis requires the JNK1-
dependent degradation of the caspase-8 inhibitor, c-FLIPL.
The induced degradation of c-FLIPL, which is mediated by
the 26S proteasome, requires activation of the JNK1-
responsive ubiquitin ligase Itch, which specifically interacts
with the long isoform of c-FLIP.
These results are satisfying because they are consistent
with many previous observations to which they provide
new and important mechanistic insights. First and foremost,
JNK1 promotes apoptosis by directly antagonizing a critical
NF-kB-dependent antiapoptotic step. It was established
that the primary mechanism by which NF-kB activation, dur-
ing early stages of TNFR1 signal transduction, prevents ac-
tivation of caspase-8 through complex II depends on induc-
tion of c-FLIP (Micheau and Tschopp, 2003). Furthermore,
ablation of the c-Flip gene renders cells sensitive to TNFa-
induced apoptosis even without inhibition of NF-kB or mac-
romolecular synthesis (Yeh et al., 2000). In addition, c-FLIP
but not another NF-kB-dependent antiapoptotic regulator,
cIAP1, blocks TNFa-induced cell death (Micheau et al.,
2001). We now show that JNK1 antagonizes the very
same process that blocks TNFa-induced death in response
to NF-kB activation, by promoting c-FLIPL degradation. Sec-
ond, the progression from TNFR1 ligation to caspase-8
activation in cells with compromised NF-kB activity depends
on formation at later time points of the soluble complex II,
whose assembly depends on binding of RIP1, TRAF2, and
TRADD to the caspase-8 activator FADD (Micheau and
Tschopp, 2003). Yet the ability of complex II to activate cas-
pase-8 is inhibited by c-FLIP, whose synthesis is induced by
NF-kB. We now show in three different pathophysiologically
relevant in vivomodels that injection of ConA, LPS plus GalN,
or TNFa plus GalN intomice results in degradation of c-FLIPL
(Figures 2A and 6E) with very similar kinetics to those of pro-610 Cell 124, 601–613, February 10, 2006 ª2006 Elsevier Inc.caspase-8 recruitment to FADD (Figure 2D). These bio-
chemical changes correlate with induction of fulminant liver
failure associated with hepatocyte apoptosis. By contrast,
in Jnk1/ mice, which are resistant to ConA-induced liver
failure (Maeda et al., 2003), ConA injection does not lead
to c-FLIPL degradation (Figure 2A), and therefore FADD ac-
tivation results in recruitment of c-FLIPL at the expense of
caspase-8 (Figure 2D). Injection of a specific JNK-inhibitory
peptide into wt mice treated with either ConA (Figure 3B)
or LPS plus GalN (Figure 6E) also blocked c-FLIPL ubiquiti-
nation and degradation and caspase-8 cleavage.
We also observed that JNK1-induced c-FLIP degradation
is specific to the c-FLIPL isoform and does not apply to
c-FLIPS (Figures 5B and 5C). Specificity is due to the selec-
tive interaction of c-FLIPL with Itch, mediated by its CASP
domain, which is absent from c-FLIPS or FLIPR. This result
may explain why activated T cells mainly upregulate c-FLIPS
and thereby resist activation-induced death (Kirchhoff et al.,
2000a, 2000b).We previously found that potent T cell activa-
tion results in the JNK1-dependent activation of Itch (Gao
et al., 2004). This is expected to prevent the accumulation
of c-FLIPL by inducing its degradation but have no effect
on c-FLIPS, the very isoform found to accumulate in strongly
activated T cells. Conversely, c-FLIPL was found to be the
relevant inhibitor of caspase-8 activation by TNFa (Micheau
and Tschopp, 2003). Furthermore, c-FLIPL is the predomi-
nant form of FLIP in the liver, present even prior to TNFa chal-
lenge, an observation that explains why TNFa-induced apo-
ptosis in hepatocytes is prevented by proteasomal inhibitors,
which may enhance apoptosis in other cell types. Thus, cell
type-specific modulation of c-FLIP isoform expression levels
may strongly affect the ability of JNK1-dependent Itch acti-
vation to promote apoptosis in response to engagement of
TNFR1 or other receptors.
Interestingly, Itch is the second HECT domain E3 ubiquitin
ligase found to control programmed cell death through
ubiquitin-induced degradation of antiapoptotic proteins. Re-
cently, another HECT domain ubiquitin ligase, Mule/ARF-
BP1, was shown to catalyze the ubiquitin-dependent elimi-
nation of Mcl-1 during DNA-damage-induced apoptosis
(Zhong et al., 2005). Thus, there may be a newly emerging
but general role for HECT domain ubiquitin ligases as posi-
tive regulators of apoptosis through their ability to catalyze
polyubiquitination of antiapoptotic proteins. It would be of in-
terest to examine whether like Itch (Gao et al., 2004), Mule
activity is also controlled by its phosphorylation.
The present results lead to a further refinement of the two-
step model of TNFR1 signal transduction (Micheau and
Tschopp, 2003; Muppidi et al., 2004) and provide a detailed
and rather definitive explanation of the mechanism by which
the intricate interplay between NF-kB and JNK determines
the outcome of TNFa signaling (Figure 7). By inducing
c-FLIPL synthesis, NF-kB activation prevents caspase-8
activation at later time points, during which the TNFR1-
associated complex I dissociates and the FADD-containing
complex II appears. The amount of c-FLIPL in the cell deter-
mines the extent of pro-caspase-8 recruitment to FADD and
its rate of activation. At the same time, NF-kB activation
induces expression of antioxidant enzymes that keep JNK
activation in check by preserving MKP activity (Kamata
et al., 2005). However, under conditions where NF-kB activ-
ity is reduced or attenuated, the amount of newly synthe-
sized c-FLIPL decreases, and MKPs are inhibited due to ac-
cumulation of ROS. This promotes strong and sustained
JNK1 activation, which in turn activates Itch to promote
c-FLIPL degradation. As Itch phosphorylation is reversible,
prolonged JNK1 activation is required for maintaining Itch
in an activated state needed for inducing the decay of the
entire c-FLIPL pool. This facilitates the recruitment of pro-
caspase-8 to FADD and its subsequent activation. Thus,
even subtle changes in the relative activities of NF-kB and
JNK1 can have rather dramatic effects on the ability of
TNFa to induce cell survival and proliferation versus cell
death. In addition to explaining why prolonged, rather
than transient, JNK activation is required for progression of
TNFa-induced apoptosis, our results also explain the recently
observed differences in the abilities of JNK1 and JNK2 to pro-
mote TNFa-induced apoptosis (Liu et al., 2004), as only
JNK1 and not JNK2 can lead to Itch phosphorylation and ac-
tivation (Gao et al., 2004).
EXPERIMENTAL PROCEDURES
Animals
Mice deficient in either IKKb in either all cells or only in hepatocytes
(Maeda et al., 2003), JNK1 (Chang et al., 2003), or Itch (Fang et al.,
Figure 7. TNFa-Induced Apoptosis Depends on Itch Activa-
tion by JNK1 and c-FLIPL Degradation
Engagement of TNFR1 results in formation of complex I at the cytoplas-
mic tail of the receptor leading to JNK1 and IKK activation. IKK activates
NF-kB, which induces c-FLIP expression, whereas JNK1 activates Itch,
which induces c-FLIPL ubiquitination and proteasomal degradation. After
awhile, complex I dissociates from the receptor and complex II, which in-
cludes FADD, is formed. If c-FLIPL levels are high (high NF-kB, low JNK1),
caspase-8 recruitment to FADD and its subsequent activation are in-
hibited and the cells survive. If c-FLIPL levels are low (low NF-kB, high
JNK1), caspase-8 is recruited to FADD and activated, leading to apopto-
tic cell death.2002) were previously described and were backcrossed to C57BL/6
mice for more than six generations.
Primary Hepatocyte Culture
Hepatocytes were isolated and plated as described (Maeda et al., 2003).
Cell viability exceeded 90% as determined by Trypan-blue exclusion. He-
patocytes were cultured for 24 hr in arginine-free medium containing 10%
dialyzed serum to eliminate other cell types.
Gene Expression Analysis
Total cellular RNAwas extracted using TRIZOL (Invitrogen, Carlsbad, CA).
cDNA was generated using SuperScript II (Invitrogen). The relative levels
of c-FLIP, cIAP1, cIAP2, TNFa, IL-4, IFN-g, and FasL mRNAs were deter-
mined by real-time quantitative PCR (Q-PCR) using cyclophilin mRNA for
normalization (Park et al., 2002). Primer sequences are available upon re-
quest.
Immunohistochemistry
Livers were fixed in 4% formaldehyde, dehydrated, embedded in paraffin,
and sectioned (5 mm). Sections were stained with Harris hematoxylin and
eosin (H&E). TUNEL staining was as described (Maeda et al., 2003).
Liver Injury Models
ConA was injected i.v. at 25 mg/kg in PBS. Alternatively, mice were in-
jected i.p. with 35 mg/kg LPS (Sigma) and 700 mg/kg GalN (Sigma). An-
imals were sacrificed, blood was collected by cardiac puncture, and livers
were surgically removed. Serum was separated and analyzed for trans-
aminase and TNFa levels and liver histology was analyzed by H&E stain-
ing (Maeda et al., 2003).
Immunochemistry and Kinase Assays
For immunoprecipitations, lysates were mixed with antibodies (1 mg) for
2 hr, followed by addition of 30 ml of proteinA/G Plus-Sepharose beads
(Santa Cruz Biotechnology, Santa Cruz, CA) for an additional hr at 4ºC.
Immunoprecipitates were washed three times with RIPA buffer and boiled
in Laemmli buffer. Samples were separated on 12% NuPAGE gels (Invi-
trogen) or by standard SDS-PAGE and electrotransferred to PVDF mem-
branes. Membranes were probed with primary antibodies (1 mg/ml), fol-
lowed by horseradish peroxidase-conjugated secondary antibodies,
washed and visualized with chemiluminescence detection system
(Pierce). We used polyclonal antibodies against caspase-8 (Cell Signal-
ing), c-FLIP (Stressgene), RIP1 (Cell Signaling), p21 (Santa Cruz Biotech),
and Bid (Gift from Dr. J. Reed) and monoclonal antibodies against HA
(Roche), Myc, His (Invitrogen), c-FLIP (Alexis), actin (Sigma), FADD
(Stressgene), ubiquitin, IkBa (Imgenex) JNK1, caspase-3, and cyto-
chrome c (BD biosciences).
Glutathione S-transferase (GST)-Itch fusion proteins were expressed
and purified as described (Fang et al., 2002). Proteins were in vitro tran-
scribed and translated in reticulocyte lysates (Promega). For pull-down
assays, GST fusion proteins (5 mg) were mixed with in vitro translates
and incubated at 4ºC for 4 hr, followed by addition of 30 ml of GSH-
Sepharose beads (Amersham Pharmacia) for 30 min. Precipitates were
washed four times with lysis buffer, eluted in Laemmli buffer, and sepa-
rated on 12% NuPAGE gels and immunoblotted as above. JNK immuno-
complex kinase assays were as described (Maeda et al., 2003).
Metabolic Labeling and Pulse-Chase Experiment
Transfected 293T cells were grown to confluence, washed with PBS, and
incubated at 37ºC for 1 hr in serum-free DMEM without methionine and
cysteine. Cells were pulse-labeled for 2 hr with 200 mCi ProMix L-[35S]me-
thionine and cysteine (Amersham Biosciences), washed extensively with
unlabeled DMEM, and chased at 37ºC in DMEM containing serum and
supplemented with unlabeled methionine and cysteine (Sigma). At the in-
dicated times cells were washed with PBS and lysed.Cell 124, 601–613, February 10, 2006 ª2006 Elsevier Inc. 611
Plasmids and Cell Transfection
Fibroblasts fromwt, Ikkb/, and Itch/ (Bai et al., 2004) mouse embryos
and 293T cells were cultured in DMEM plus 10% fetal calf serum (FCS).
c-FLIP expression plasmids encoding HA-tagged full-length (FLIPL), short
form (FLIPS), caspase-8 like domain (CASP) and the DEDs were trans-
fected into cells using Lipofectamine 2000 (Invitrogen). Human recombi-
nant TNFa and IL-1 were from R&D Systems (Minneapolis, MN). The pro-
tease inhibitor MG132 and JNK inhibitor D-JNKi were from Calbiochem.
The proteasome inhibitor bortezomib (PS-341) was a gift from Millennium
Pharmaceuticals (Boston).
Lentivirus Constructs and Infection
Lentivirus expressing GFP under control of CMV promoter was kindly pro-
vided by Dr. I. Verma (Salk Institute). Myc-tagged p43-c-FLIP, HA-JNK1,
Itch, or Itch (AA) cDNAs were PCR amplified and subcloned into lentivirus
vector pLL3.7 (Dull et al., 1998). Titers were determined by infecting wt
fibroblasts with serial dilution of concentrated lentivirus. For scoring p43-
c-FLIPL-positive cells, infected cells were immunostained with anti-Myc
antibody and visualized with Rhodamine. For GFP expression, infected
cells were examined and scored under an inverted microscope (Zeiss).
The titers were approximately 1–10  108 infectious units (IFU) per ml.
Supplemental Data
Supplemental data include five figures and can be found with this article
online at http://www.cell.com/cgi/content/full/124/3/601/DC1/.
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